Investing

United Therapeutics (UTHR) Up 31% On Big Profits

United Therapeutics (UTHR) is up 31% to a new 52-week high at $89.

The company had a home run quarter. Total revenues for the third quarter of 2007 were $59.0 million, up 46% from $40.4 million for the third quarter of 2006. Net income for the third quarter of 2007 was $14.8 million, or $0.70 per basic share, up 74% from $8.5 million, or $0.37 per basic share, in the third quarter of 2006.

Cardiovascular product revenue rose almost 90%. This segment is over half of the company’s revenue.

Douglas A. McIntyre

 

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.